Abiopharma

DESIGN THERAPEUTICS, INC. (DSGN) Announces Executive and Board Changes DESIGN THERAPEUTICS, INC. (DSGN) announced changes to its leadership team and board of directors. The position includes: Class III, Governance Committee, Nominating Committee, Nominating and Corporate Governance Committee. The change is effective as of March 31, 2026. Executive Changes Details:

• Actions: Appointed
• Committee Assignments: Governance Committee, Nominating Committee, Nominating and Corporate Governance Committee
• Effective Date: March 31, 2026
• Board Classification: Class III